Researchers studied the effects of embelin on the p38 MAPK pathway in a mouse model of MS. Embelin showed potential as a therapeutic agent for MS due to its anti-inflammatory properties.
Embelin from Embelia plants inhibits cancer cell growth via multiple mechanisms, making it a promising anticancer agent supported by scientific literature. Consider its potential for your lab's research on cancer treatment.
Embelia ribes (ER) and embelin show promise in treating diabetes mellitus by significantly reducing blood glucose and improving insulin levels in experimental rat studies. Further clinical trials are needed to confirm these findings.